Pricing

Atheronova Inc (AHROQ)

followers ·
Sector:
REAL ESTATE
Industry:
REAL ESTATE
SIC:
LAND SUBDIVIDERS & DEVELOPERS (NO CEMETERIES)
CEO:
Employees:
3
2301 DUPONT DRIVE, SUITE 525, IRVINE, CA, 92612
(949) 525-5471

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

    Formally known as:
  • ATHERONOVA INC COM STK
  • Atheronova, Inc.
Stock Split History
DateRatio
2006-06-30 1:1
2010-06-28 1:2
2014-04-22 1:10
AtheroNova Inc., a development stage company, is engaged in the research, development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. The company develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. Its lead compound includes AHRO-001, an active pharmaceutical ingredient. The company also focuses on developing various applications for its patented and patents-pending therapies in market sectors that comprise cardiovascular disease, stroke, and peripheral artery disease. AtheroNova Inc. was founded in 2006 and is based in Irvine, California.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available